InnoCare has dosed the first patient in a global Phase II study of Soficitinib (ICP-332), a selective TYK2 inhibitor,...

Dipharma reports a new analytical approach that combines 15N‑enriched nitrosating reagents with 15N NMR readout to selectively detect and...

HUTCHMED will take a multi-asset slate to ESMO Asia and ASH in early December, flagging new and updated readouts...

A ≥48-month interim analysis from Xenon’s ongoing seven-year X-TOLE open-label extension will be featured at AES 2025, focusing on...

Scilex has exercised a pre-funded warrant for 263,914,094 shares of Datavault AI, a stake valued at approximately $583.3 million...

No new efficacy numbers were disclosed, but Celcuity will present updated subgroup and safety results from the randomized Phase...

FibroBiologics has repaid all amounts outstanding under its Yorkville-issued convertible promissory notes, removing the prospect of further conversions into...

Tangram Therapeutics has submitted a Clinical Trial Application to the UK MHRA to begin a Phase 1/2 study of...

Tiziana Life SciencesLife Sciences’ intranasal anti-CD3 antibody, foralumab, has been accepted into the ALS MyMatch Program at the Healey...

BriaCell will present survival readouts from its Phase 2 study of the allogeneic whole cell vaccine Bria-IMT and new...